ID   HAP1 INPP5E (-) 2
AC   CVCL_SS69
SY   HZGHC002902c002; INPP5E knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SS69
DR   Horizon_Discovery; HZGHC002902c002
DR   Wikidata; Q54875764
RX   PubMed=28031327;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; 21474; INPP5E.
CC   Sequence variation: Gene fusion; HGNC; 76; ABL1 + HGNC; 1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 05-10-23; Version: 10
//
RX   PubMed=28031327; DOI=10.1128/mcb.00500-16;
RA   Sierra Potchanant E.A., Cerabona D., Sater Z.A., He Y., Sun Z.-J.,
RA   Gehlhausen J., Nalepa G.;
RT   "INPP5E preserves genomic stability through regulation of mitosis.";
RL   Mol. Cell. Biol. 37:e00500.16.1-e00500.16.21(2017).
//